These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1696322

  • 21. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
    Harvey WH, Fleming TR, Beltran G, Saiers JH, Oishi N, Von Hoff DD.
    Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482
    [No Abstract] [Full Text] [Related]

  • 22. A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
    Grever MR, Benedetti J, Balcerzak SP, Taylor SA, Miller TP, Dakhil SR.
    Invest New Drugs; 1994 Nov; 12(3):259-61. PubMed ID: 7534752
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P, Fierro MT, Rossotto GL, Savoia P, Bernengo MG.
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB.
    Blood; 1989 Jul; 74(1):19-25. PubMed ID: 2473795
    [Abstract] [Full Text] [Related]

  • 29. Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Weiss GR, Crowley J, Von Hoff DD, Taylor SA, Belt RJ, Coltman CA, Hynes HE, Costanzi JJ.
    Cancer Treat Rep; 1986 Sep; 70(9):1123-4. PubMed ID: 2427196
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors. A Southwest Oncology Group trial.
    Taylor SA, Crowley J, Vogel FS, Townsend JJ, Eyre HJ, Jaeckle KA, Hynes HE, Guy JT.
    Invest New Drugs; 1991 May; 9(2):195-7. PubMed ID: 1714887
    [Abstract] [Full Text] [Related]

  • 32. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG, Leyland-Jones B, Cheson BD.
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM, Redman JR, Keating MJ.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [Abstract] [Full Text] [Related]

  • 39. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
    Redman JR, Cabanillas F, Velasquez WS, McLaughlin P, Hagemeister FB, Swan F, Rodriguez MA, Plunkett WK, Keating MJ.
    J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
    [Abstract] [Full Text] [Related]

  • 40. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Solal-Céligny P, Brice P, Brousse N, Caspard H, Bastion Y, Haïoun C, Bosly A, Tilly H, Bordessoule D, Sebban C, Harousseau JL, Morel P, Dupas B, Plassart F, Vasile N, Fort N, Leporrier M.
    J Clin Oncol; 1996 Feb; 14(2):514-9. PubMed ID: 8636765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.